Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mathilde Weisz Ejlsmark"'
Autor:
Anne L. H. Bisgaard, Carsten Brink, Tine Schytte, Rana Bahij, Mathilde Weisz Ejlsmark, Uffe Bernchou, Anders S. Bertelsen, Per Pfeiffer, Faisal Mahmood
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background and purposeBiomarkers for prediction of outcome in patients with pancreatic cancer are wanted in order to personalize the treatment. This study investigated the value of longitudinal diffusion-weighted magnetic resonance imaging (DWI) for
Externí odkaz:
https://doaj.org/article/28104d735b244123a85c34d678a8bda1
Autor:
Mathilde Weisz Ejlsmark, Tine Schytte, Uffe Bernchou, Rana Bahij, Britta Weber, Michael Bau Mortensen, Per Pfeiffer
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6820-6837 (2023)
Pancreatic cancer is rising as one of the leading causes of cancer-related death worldwide. Patients often present with advanced disease, limiting curative treatment options and therefore making management of the disease difficult. Systemic chemother
Externí odkaz:
https://doaj.org/article/84c8ef3ae4404d2e855f9ea004735ac8
Autor:
Per Pfeiffer, K R Schønnemann, Stine Braendegaard Winther, Mathilde Weisz Ejlsmark, Merete Krogh, Jon Kroll Bjerregaard, Helle Anita Jensen
Publikováno v:
Winther, S B, Bjerregaard, J K, Schonnemann, K R, Ejlsmark, M W, Krogh, M, Jensen, H A & Pfeiffer, P 2018, ' S-1 (Teysuno) and gemcitabine in Caucasian patients with unresectable pancreatic adenocarcinoma ', Cancer Chemotherapy and Pharmacology, vol. 81, no. 3, pp. 573–578 . https://doi.org/10.1007/s00280-018-3528-5
PURPOSE: Gemcitabine has been standard of care in advanced pancreatic adenocarcinomas (PC) for almost two decades. Randomized, primarily Japanese, studies have shown promising efficacy when combined with S-1 (GemS-1); however, no data are published i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9970c5b1ee7299ad820c5800d2fedc51
https://doi.org/10.1007/s00280-018-3528-5
https://doi.org/10.1007/s00280-018-3528-5
Autor:
Olfred Hansen, Lars Bastholt, Mathilde Weisz Ejlsmark, Charlotte Kristiansen, Jesper Grau Eriksen
Publikováno v:
Ejlsmark, M W, Kristiansen, C, Eriksen, J G, Hansen, O & Bastholt, L 2017, ' Recall radiation myelitis after stereotactic radiation and dabrafenib in metastatic melanoma ', Acta Oncologica, vol. 56, no. 1, pp. 109-110 . https://doi.org/10.1080/0284186X.2016.1246802
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c242eee8e0680020b548a3b5a7e205
https://pubmed.ncbi.nlm.nih.gov/27830981
https://pubmed.ncbi.nlm.nih.gov/27830981